 |
|
SEVERAL RECENT ARTICLES ON THE EFFECTIVENESS OF USING DONORS OTHER THAN HLA-MATCHED SIBLINGS, INCLUDING MATCHED UNRELATED DONORS AND UMBILICAL CORD BLOOD PRODUCTS
I. RECENT REVIEWS, Citations 1-8
Allogeneic hematopietic cell transplantation for AML when a matched related donor is not available. Appelbaum F.
Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group. Schetelig J,et al.
Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia. Moore J, et al.
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study. Eapen M, et al.
Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor. Ringdén O, et al.
Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival. Kumar P, et al..
Unrelated cord blood transplantation after myeloablative conditioning in adults with acute myelogenous leukemia. Ooi J, et al.
Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Atsuta Y, et al.